Conference Coverage

Targeting inactivity, mood, and cognition could be key to reducing OA mortality


 

REPORTING FROM OARSI 2018


“This type of mediation analysis has not been done in the osteoarthritis field before,” Mr. Parmar observed. He conceded that the mediators found might actually have contributed to the development of OA and that pain interference used in the definition of OA could have been caused by other factors.

Nevertheless, these data suggest that there may be actionable factors that could be used in primary care to reduce mortality in OA.

Mr. Parmar suggested that “encouraging physical activity and considering the impact of comorbidities can help reduce the risk of mortality in adults with osteoarthritis.”

The study was funded by Arthritis Research UK, the North Staffordshire Primary Care Consortium, and the Medical Research Council. Mr. Parmar had no conflicts of interest to disclose.

Pages

Recommended Reading

Pediatric psoriasis linked to multiple psychiatric comorbidities
MDedge Rheumatology
Screen opioid users for depression, study recommends
MDedge Rheumatology
New report highlights gaps in knowledge on marijuana use
MDedge Rheumatology
Brodalumab approved for psoriasis with REMS required
MDedge Rheumatology
SPECT reveals perfusion problems in antiphospholipid syndrome
MDedge Rheumatology
Depressed OA patients get far-reaching benefits from Internet-delivered CBT
MDedge Rheumatology
Psoriasis patients face higher risk of alcohol-related death – but lower suicide risk
MDedge Rheumatology
Guselkumab tops adalimumab for psychiatric comorbidities in psoriasis
MDedge Rheumatology
Use of opioids, SSRIs linked to increased fracture risk in RA
MDedge Rheumatology
RA associated with higher risk of psychiatric disorders
MDedge Rheumatology